Crosscope
Techstars '20Mountain View, US · 1 known investors
Find your way into Crosscope
Sign up to find every way you can get introduced to Crosscope
- Your email: who you already know at Crosscope, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Crosscope team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Crosscope develops AI and machine learning technology for cancer screening and pathology diagnosis. The company provides computer-assisted diagnostic imaging analysis and automated image analysis tools for pathologists to improve workflow efficiency and diagnostic accuracy.
Investors · 1
Techstarslisted by TechstarsBoulder · $220K
How we know: the Techstars portfolio · Not right? Tell us
Related companies · 2
OmniscopeOmniscope develops diagnostics and therapeutics technology based on the convergence of AI and immunology, aiming to interpret immune system data to generate therapeutics, develop diagnostics, and monitor patients. Founded in 2020, the company applies machine learning to immunology with a focus on health equity.
TellescopeTellescope provides a unified platform for digital health companies to manage patient communications, appointments, and care team operations. The platform includes patient portals, workflow automation, telehealth capabilities, and integrations with existing EHR systems.
Companies working in the same space as Crosscope.
Frequently asked questions
- What does Crosscope do?
- Crosscope develops AI and machine learning technology for cancer screening and pathology diagnosis. The company provides computer-assisted diagnostic imaging analysis and automated image analysis tools for pathologists to improve workflow efficiency and diagnostic accuracy.
- Who are Crosscope's investors?
- Crosscope's investors include Techstars.
- Where is Crosscope headquartered?
- Crosscope is headquartered in Mountain View, US.


